Skip to content

Quantitative muscle ultrasound of orofacial muscles in children with cerebral palsy

Quantitative muscle ultrasound of orofacial muscles in children with cerebral palsy - Orofacial muscle ultrasound in CP

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46117
Enrollment
50
Registered
2018-09-24
Start date
2018-11-28
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spasticity

Interventions

None listed

Sponsors

afdeling Logopedie (kinderen), Afdeling Revalidatie
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Age 3-18 years Diagnosis of spastic cerebral palsy Signed informed consent by parents (and the patient when aged above 12 years).

Exclusion criteria

Exclusion criteria: - Medication to reduce saliva production (glycopyrrolate, scopolamine, trihexyfenidyl) - Treatment with botulin toxin injections in the salivary glands in the past 32 weeks - Surgical treatment for drooling in the past. These exclusion criteria are included because they influence the functional outcome measurements.

Design outcomes

Primary

MeasureTime frame
- Thickness of orofacial muscles (digastrics muscle, masseter muscle, temporal muscle, tongue) and described as z-score (corrected for age, height and weight, based on own laboratory normal values). - Echogenicity of orofacial muscle (digastrics muscle, geniohyoid muscle, masseter muscle, temporal muscle) and described as z-score (corrected for age, height and weight, based on own laboratory normal values).

Secondary

MeasureTime frame
- Performance of mastication (Mastication Observation Evaluation) - EDACS level - Drooling Quotient - Timed Test of Swallowing (ml/sec) - Pediatric Posterior Drooling Scale

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)